• News & Media
  • Careers
  • Contact Us
  • ""
  • Home
  • About Us
  • BUSINESSES
  • Foundation
  • Investors
    News & Media Careers Contact Us
    • Home
    • About Us
      • Who We Are
      • Our Values
      • Our History
      • Board of Directors
      • Management Team
    • Business
      • Piramal Enterprises Ltd.
      • Piramal Pharma Ltd.
      • Piramal Realty
    • Foundation
    • investor
      • Piramal Enterprises Ltd
      • Piramal Pharma Ltd
    • Privacy Policy
    • Disclaimer
    • © 2022 Piramal Enterprises Ltd.
    • Financial
      Reports
    • Corporate
      Governance
    • Shareholder
      Information
    • Investor
      Contacts

    Shareholder Information
    & Services

    1. Investors
    2. Piramal Pharma Limited
    3. Shareholder Information
    4. Announcements

    Announcements

    • Announcements
    • Composite Scheme of Arrangement
    • Credit Rating
    • Shareholding
      Pattern
    • Rights Issue
    • PPL- Newspaper advertisement of Postal Ballot Notice

    • PPL-Stock Exchange intimation – Submission of Postal Ballot Notice.

    • PPL Postal Ballot Notice – February, 2023

    • PPL-Newspaper Advertisement – Extract of Consolidated Financial Results for the quarter and nine months ended 31st December, 2022

    • PPL-Newspaper Advertisement – Extract of Consolidated Financial Results for the quarter and half year ended 30th September, 2022

    • Auditors Report with UDIN for quarter and nine months ended 30th December, 2022

    • PPL – Outcome of Board meeting – 08th February, 2023

    • Receipt of request seeking reclassification from ‘ Promoter group’ category to ‘Public’ category of Piramal Pharma Limited

    • PPL – Update on Board Meeting Intimation – 08th February, 2023

    • PPL – Board meeting Intimation – 8th February, 2023

    • US FDA Inspection – Sellersville

    • US FDA Inspection – Lexington

    • Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    • Related Party Transaction – 30th September, 2022

    • PPL – Newspaper Advertisement – Extract of Consolidated Financial Results for the Quarter and Half year ended 30th September, 2022

    • Auditors Report with UDIN for quarter and half year ended 30th September, 2022

    • PPL – Outcome of Board Meeting – 08th November, 2022

    • Intimation of Schedule of Analyst Call

    • US FDA inspection Riverview

    • PPL – Intimation of Contact Details of Key Managerial Personnel for determining materiality of Event/making disclosures to Stock Exchange

    • PPL – Board Meeting Intimation – 8th November, 2022

    Piramal Group
    • Piramal Enterprises Ltd.(PEL)
    • Piramal Pharma Ltd.(PPL)
    • Piramal Realty
    • Piramal Foundation
    Piramal Enterprises Ltd.
    • Financial Services
    • – Piramal Capital & Housing Finance Limited   (PCHFL)
    • – Piramal Alternatives (PA)
      • Piramal Credit Fund (PCF)
      • India Resurgence Fund (IndiaRF)
    Piramal Pharma Ltd.
    • Piramal Pharma Ltd.
    • – Pharma Solutions
    • – Critical Care
    • – Consumer Products
    • – Allergan India Private Limited
    Piramal Realty
    • – Piramal Mahalaxmi
    • – Piramal Aranya
    • – Piramal Revanta
    • – Piramal Vaikunth
    • – Piramal Agastya
    Piramal Foundation
    • – Piramal Swasthya
    • – Piramal School of Leadership
    • – Piramal Sarvajal

    © 2023 Piramal Enterprises Ltd.

    • Privacy Policy
    • Disclaimer